Genentech
South San Francisco · Founded 1976
About Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche.
Company Facts
- Founded: 1976
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 10,001+
- Estimated revenue: $10M+
- Funding stage: M&A
- Last round: Series Unknown (Jan 1976)
- Ticker: nyse:DNA
- Website: gene.com
- Phone: +1-888-835-2555
Industries & Categories
Biotechnology, Life Science, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/genentech-49248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.